The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-((3,4-Dichlorobenzyl)oxy)-2-fluorobenzyl)azetidine-3-carboxylic Aci ID: ALA3741298
PubChem CID: 59451849
Max Phase: Preclinical
Molecular Formula: C18H16Cl2FNO3
Molecular Weight: 384.23
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2F)C1
Standard InChI: InChI=1S/C18H16Cl2FNO3/c19-15-4-1-11(5-16(15)20)10-25-14-3-2-12(17(21)6-14)7-22-8-13(9-22)18(23)24/h1-6,13H,7-10H2,(H,23,24)
Standard InChI Key: ZQUQFQGNDHGASO-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
2.5951 -3.0039 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6522 -4.0166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5879 -5.0735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5309 -4.0092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5795 -6.5683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5373 -7.1631 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6155 -7.1737 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6003 1.4977 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8990 0.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2003 1.4932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4994 0.7432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7985 1.4932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7985 2.9932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4995 3.7432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2004 2.9933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3383 1.3500 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-6.4995 4.9432 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-8.8378 3.5932 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
1 4 1 0
5 6 2 0
5 7 1 0
3 5 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
9 14 2 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
17 22 2 0
15 16 1 0
12 15 1 0
1 8 1 0
10 23 1 0
21 24 1 0
20 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 384.23Molecular Weight (Monoisotopic): 383.0491AlogP: 4.23#Rotatable Bonds: 6Polar Surface Area: 49.77Molecular Species: ACIDHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 2.41CX Basic pKa: 7.21CX LogP: 1.63CX LogD: 1.32Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.81Np Likeness Score: -1.48
References 1. Hobson AD, Harris CM, van der Kam EL, Turner SC, Abibi A, Aguirre AL, Bousquet P, Kebede T, Konopacki DB, Gintant G, Kim Y, Larson K, Maull JW, Moore NS, Shi D, Shrestha A, Tang X, Zhang P, Sarris KK.. (2015) Discovery of A-971432, An Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonist for the Potential Treatment of Neurodegenerative Disorders., 58 (23): [PMID:26509640 ] [10.1021/acs.jmedchem.5b00928 ]